Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC)
- 30 November 1987
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (11), 1735-1738
- https://doi.org/10.1016/0360-3016(87)90171-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Radiotherapy and cis-diammine dichloroplatinum (II) as a combined treatment modality for inoperable non-small cell lung cancer: A dose finding studyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Radiation and Platinum Drug InteractionInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1985
- External beam treatment of unresectable lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Feasibility study on daily administration of cis-diamminedichloroplatinum(II) in combination with radiotherapyRadiotherapy and Oncology, 1984
- Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Daily cis-dichlorodiammineplatinum (II) as a radio-enhancer: A preliminary toxicity reportZeitschrift für Krebsforschung und Klinische Onkologie, 1983
- Misonidazole and radiotherapy in lung cancer: A randomized double-blind trialInternational Journal of Radiation Oncology*Biology*Physics, 1982
- A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchusInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Patterns of failure in patients with inoperable carcinoma of the lungCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958